The Vbeam was introduced in the 1980s and is one of the safest and most widely used lasers in aesthetic medicine today.
The Vbeam laser is a safe, gentle, and versatile device. It delivers intense bursts of light to the skin of the face, neck, or chest. The light is absorbed by undesirable blood vessels on the surface of the skin, resulting in reduced redness and a more even complexion. It utilizes a cool cryogen spray (DCD) that accompanies the laser pulse, protecting the skin and making the treatment very comfortable.
- 1 BEFORE & AFTER PHOTOS
- 2 What is Vbeam used for?
- 3 Frequently Asked Questions about Vbeam Perfecta Laser Treatments
BEFORE & AFTER PHOTOS
What is Vbeam used for?
The Vbeam laser, recognized for its long record of safety and efficacy, is used to treat:
Telangiectasias, or facial and nasal spider veins, are typically a result of sun exposure or an after-effect of acne or rosacea. These tiny broken veins in the face cause a persistent flushed looked and have the visual effect of aging the face. They are worsened by heat, alcohol, tobacco, and sun. Skin that is prone to these broken vessels should be treated gently and cared for with mild products. Sunscreens and hats will afford a level of protection that will help maintain your cleared skin during and after treatment.
Rosacea is a chronic and potentially life-disruptive disorder of the facial skin. It typically begins any time after age 30, as redness on the cheeks, nose, chin, or forehead. It may come and go. Over time, the skin becomes ruddier and more persistent, and visible blood vessels may appear. Left untreated, bumps and pimples often develop, and in severe cases the nose may grow swollen and bumpy from excess tissue.
Vbeam has been proven to substantially reduce and often eliminate the redness and flushing of rosacea. Another procedure that is very useful in rosacea treatment is called Photofacial, which uses intense pulsed light (IPL) technology. These IPL treatments and Vbeam laser treatments are commonly used together in a rosacea treatment program for their additive effects5.
Red Acne Scars
The red color left behind on the skin from acne scars is a result of tiny broken capillaries at the site of the healed acne lesion. This redness is more common to newer acne scars and is hard to conceal, making the evidence of acne more pronounced, even after it has healed. Lasers, which target these broken capillaries, cause the small vessels to coagulate and be reabsorbed by the body. This effectively removes the redness. The Vbeam laser is often used in combination with other lasers which smooth out the acne scars, such as Fraxel or Smoothbeam.
Leg spider veins
Age, pregnancy, and heredity play a large part in the development of varicose and spider veins. Varicose veins are better treated by sclerotherapy, while small red and purple spider veins (hemorrhagic telangiectasia) are easily and comfortably treated by vascular lasers such as the Vbeam 4.
Raised or puffy scars that are often caused by surgery, trauma, acne or burns are well-treated by Vbeam Perfecta3, especially when combined with other therapies.
Frequently appearing after pregnancy or periods of rapid weight gain and loss, such as during puberty and growth spurts, stretch marks are commonly found on the stomach, thighs, buttocks, breasts, shoulders, and lower back, stretch marks can leave red, purple, or white discoloration. Vbeam works to correct the color changes associated with stretch marks10.
Frequently Asked Questions about Vbeam Perfecta Laser Treatments
How much will Vbeam laser treatment cost?
What is the treatment like, does it hurt, and is downtime required?
How many treatments are required and at what interval?
Can Vbeam treatment be combined with other therapies?
What precautions should be taken before and after treatment?
1. Bae, Y.S.; NG, E.; Geronemus, R.G.; Successful treatment of two pediatric port wine stains in darker skin types using 595 nm laser. Lasers Surg Med. 2016 Apr;48(4):339-42. doi: 10.1002/lsm.22467. Epub 2016 Jan 8.
2. Su Q1, Lin T, Wu Q, Wu Y, Guo L, Ge Y.; Efficacy of 595nm pulsed dye laser therapy for Mibelli angiokeratoma.J Cosmet Laser Ther. 2015;17(4):209-12. doi: 10.3109/14764172.2014.1003242. Epub 2015 Feb 6.
3. Sang Ju Lee , Se Yeong Jeong, Yeon A No, Kui Young Park , Beom Joon Kim; Combined Treatment with Botulinum Toxin and 595-nm Pulsed Dye Laser for Traumatic Scarring; Ann Dermatol Vol. 27, No. 6, 2015
4. Halachmi S1, Israeli H, Ben-Amitai D, Lapidoth M.; Treatment of the skin manifestations of hereditary hemorrhagic telangiectasia with pulsed dye laser.Lasers Med Sci. 2014 Jan;29(1):321-4. doi: 10.1007/s10103-013-1346-x. Epub 2013 May 17.
5. Nymann P, Hedelund L, Haedersdal M.; Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial.J Eur Acad Dermatol Venereol. 2010 Feb;24(2):143-6.
6. KJELL M. KAUNE MD, ELLEN HAAS MD, STEFFEN EMMERT MD, MICHAEL P. SCHÖN MD andMARKUS ZUTT MD; Successful Treatment of Severe Keratosis Pilaris Rubra with a 595-nm Pulsed Dye Laser; Dermatologic Surgery, Volume 35, Issue 10, pages 1592–1595, October 2009
7. Donelan MB1, Parrett BM, Sheridan RL.Pulsed dye laser therapy and z-plasty for facial burn scars: the alternative to excision. Ann Plast Surg. 2008 May;60(5):480-6. doi: 10.1097/SAP.0b013e31816fcad5.
8. Attia, Enas A.S.a; Abd El-Aziz, Yasser A.b; Elsayed, Shereen B.c; Tawfiek, Sameh K.F.d A pilot study on serum cutaneous T-cell-attracting chemokine in acne patients: effect of low-fluence long pulsed dye laser therapy; Journal of the Egyptian Women’s Dermatologic Society:May 2014 – Volume 11 – Issue 2 – p 103–108 doi: 10.1097/01.EWX.0000443806.24424.44
9. Galeckas KJ1, Ross EV, Uebelhoer NS. A pulsed dye laser with a 10-mm beam diameter and a pigmented lesion window for purpura-free photorejuvenation.Dermatol Surg. 2008 Mar;34(3):308-13. doi: 10.1111/j.1524-4725.2007.34063.x. Epub 2007 Dec 19.
10. Hilda Justiniano, Andrea Willey, Suzanne L. Kilmer; Scars, Keloids, and Stretch Marks; Chapter, Laser and IPL Technology in Dermatology and Aesthetic Medicine
pp 177-187; Date: 08 October 2010